AltaThera Pharmaceuticals, a pharmaceutical company focused on pioneering therapies to address critical gaps in cardiac care, is excited to be participating in the upcoming Midwest Pediatric Cardiology Society (MWPCS) Annual Meeting hosted in Pittsburgh, PA from September 10 – 11, 2026.
Attendees are welcome to stop by the AltaThera booth to learn more about our company and Sotalol IV (sotalol hydrochloride injection). Schedule a meeting with us in advance by contacting us at https://www.altathera.com/contact.
Learn more about the event here: https://www.mwpcs.org/
BOXED WARNING: Life-Threatening Proarrhythmia. Please see full prescribing information including boxed warning, contraindications, and dosing, at www.altathera.com/sotalol-iv-pi/.